If the medication is discontinued after attaining weight loss, a risk of rebound weight gain exists
Tesamorelin was developed right here in Canada by Theratechnologies, a Montreal-based biotech company
Serious side effects for both medications include pancreatitis (inflammation of the pancreas), vision changes, severe stomach problems, gallbladder problems, and severe allergic reactions
In June 2021, The Food and Drug Administration (FDA) approved semaglutide for the treatment of overweight with at least one weight-related condition such as diabetes, high blood pressure or high cholesterol and obesity
The profound reduction in appetite driven by these mechanisms necessitates a critical shift in dietary focus
Semaglutide is a groundbreaking medication that helps you achieve and maintain weight loss